EUCTR2004-001369-17-ES进行中（未招募）不适用
An open-label, randomized, multicenter study to evaluate the use of Zoledronic Acid in the prevention of cancer treatment-related bone loss in postmenopausal women with ER+ and/or PgR+ breast cancer receiving Letrozole as adjuvant therapy - ZoFast2406
ovartis Farmacéutica S.A.0 个研究点目标入组 400 人开始时间: 2004年9月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
- •Postmenopausal status
- •Hormone receptor positive ER and/or PgR
- •Patiens with a baseline lumbar spine and total hip BMD T-score at or above -2.0 SD
- •Patients with invasive breast cancer
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with invasive bilateral breast cancer
- •Patients with any clinical or radiological evidence of existing fracture in the lumbar spine and/or total hip
- •Patients who have received prior treatment with intravenous bisphosphonates within the past 12 months.
- •Patients with abnormal renal funtion
- •History of diseases with influence on bone metabolism
研究者
相似试验
进行中（未招募）
不适用
A randomized, open-label, multi-center study to evaluate the efficacy of nilotinib versus best supportive care with or without a tyrosine kinase inhibitor (investigator´s choice) in adult patients with gastrointestinal stromal tumors resistant to both imatinib and sunitinibGastrointestinal stromal tumors (GIST)EUCTR2006-002267-11-DEovartis Pharma Services AG237
已完成
3 期
A randomized, open-label, multi-center study to evaluate the efficacy of nilotinib versus best supportive care with or without a tyrosine kinase inhibitor (investigator's choice) in adult patients with gastrointestinal stromal tumors resistant to both imatinib and sunitinib.10017991GISTNL-OMON30672ovartis10
进行中（未招募）
不适用
A randomized, open-label, multi-center study to evaluate the efficacy of nilotinib versus imatinib in adult patients with gastrointestinal stromal tumors resistant to imatinib and resistant/intolerant to sunitinib - NDGastrointestinal stromal tumors (GIST)MedDRA version: 9.1Level: LLTClassification code 10051066Term: Gastrointestinal stromal tumourEUCTR2006-002267-11-ITOVARTIS FARMA210
已完成
3 期
A clinical trial to study the effects of Darbepoetin alfa in the treatment of anemia caused by chronic kidney disease.CTRI/2012/07/002835Hetero Drugs Limited236
进行中（未招募）
不适用
An open-label, randomised, multicentre study to evaluate the immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis adsorbed vaccine (REPEVAX) administered concomitantly versus non-concomitantly with an influenza vaccine (VAXIGRIP) to subjects of 60 years of age and olderEUCTR2010-021068-13-DESanofi Pasteur MSD S.N.C.954